TargetMol

Screening Compound Database

the primary source of leads for both High-Throughput Screening (HTS) and Virtual Screening (VS). Virtual screening enables the rapid evaluation of vast chemical spaces in a short timeframe, requiring extensive structural datasets. However, because the results of virtual screening must be validated through bioactivity assays, it is critical that these digital structures correspond to physical compounds available for immediate procurement.

Our Advantages

Large-scale Data

Over 25 million screening compounds.

Superior Structural Diversity

Tens of thousands of scaffolds, ensuring maximum chemical space coverage.

High In-stock Rate

Real-time data updates and regular library maintenance.

Robust Supply Chain Management

A decade-long established supply system providing end-to-end services, from compound sourcing and ordering to final delivery.

Guaranteed Lead Times

Mature customs clearance processes, with lead times for most products controlled within 20 days.

Core Database

Features over 20,000 bioactive compound structures and approximately 1.61 million lead-like screening molecules, characterized by exceptional structural diversity, high drug-likeness, and superior cost-effectiveness. This collection enables the discovery of high-quality, economical leads within an optimized screening scope, effectively reducing initial R&D costs while fulfilling the core requirements for drug repurposing and virtual screening.

T001

Specializes in known bioactive compounds and natural products, and is renowned for premium product quality, superior technical support, and high cost-efficiency.

(Quantity 22966)

D001

One of the world’s leading compound brands. Offers an extensive portfolio featuring over 5,000 scaffold structures and 100+ specialized compound libraries with a competitive pricing edge.

(Quantity 1563171)

Priority Database

This collection comprises 8 distinct brands, totaling 8.96 million lead-like screening compounds. Given the capacity of virtual screening to rapidly process vast chemical spaces, access to larger-scale datasets is often essential. By significantly expanding the structural diversity beyond our Core Database, this database provides researchers with a broader range of screening possibilities. It is specifically tailored for projects requiring massive structural datasets and supported by sufficient R&D budgets.

D006

US brand (San Diego); features popular diversity and macrocyclic libraries.

(Quantity 1679030)

D011

Canada brand; offers 2,900+ scaffolds with comprehensive specs and transparent pricing.

(Quantity 592703)

D008

Netherlands brand; recognized for significant and clear pricing advantages.

(Quantity 326210)

D009

US brand; utilizes a Hong Kong distribution hub for rapid delivery and moderate pricing.

(Quantity 1394907)

D019

Germany brand; specializes in natural product extraction and analog synthesis with premium quality.

(Quantity 45345)

D003

Ukraine brand; possesses robust R&D capabilities for both cost-effective and high-value molecules.

(Quantity 4734919)

D010

Russia brand; provides an extensive range of natural products and derivatives at a higher price level.

(Quantity 485658)

D012

UK brand; focuses on a specialized niche catalog with substantial physical inventory for every item.

(Quantity 53344)

Extended Database

This collection comprises 15 brands, totaling 14.28 million lead-like screening compounds. For virtual screening with sufficient computational power, the demand for accessible physical structures often exceeds available resources. Building upon the aforementioned datasets, this library incorporates an even broader range of structural types to provide researchers with a more extensive and diverse chemical space.

D020

UK brand; 20+ years of organic synthesis expertise.

(Quantity 102893)

D058

Russia brand; specializes in novel screening compound production and distribution.

(Quantity 718205)

D104

Russia brand; 20+ years of supply experience with extensive inventory and high cost-effectiveness.

(Quantity 26848)

D065

US brand; 20+ years dedicated to lead-like compounds and building blocks; premium pricing.

(Quantity 646891)

D015

Ukraine brand; rapidly growing, focused on HTS and drug discovery; higher pricing.

(Quantity 1226425)

D059

Ukraine brand; 20 years of expertise in HTS compounds and services with competitive pricing.

(Quantity 61362)

D021

US brand; 20+ years of designing unique small molecules for drug development.

(Quantity 1440338)

D013

Canada brand; specializes in specialty compounds, biochemicals, and bioanalytical reagents.

(Quantity 294641)

D137

UK brand; 30+ years of experience in compound supply and professional services.

(Quantity 5007)

D111

Russia brand; 20+ years specializing in high-quality novel compound synthesis for HTS.

(Quantity 439602)

D133

China brand; a CRO with extensive experience in professional compound synthesis.

(Quantity 247261)

D140

Ukraine brand; flexible team with 20+ years of experience in novel chemical synthesis and supply.

(Quantity 372596)

D062

US brand; extensive experience in diverse compounds and natural product supply.

(Quantity 1075147)

D144

Ukraine brand; offers ~2 million novel lead-like compounds featuring key pharmacophores.

(Quantity 2244487)

D147

High-quality small molecule provider offering unique solutions for pharma and biotech.

(Quantity 5384037)